Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Sanofi reception

Sanofi licenses cardiovascular therapy in South Korea

Phase III drug comes from Swedish company NeuroVive

Boehringer Ingelheim headquarters

Boehringer bags FDA approval for Spiriva-based combo

Stiolto given the thumbs up as a once-daily maintenance therapy for COPD

- PMLiVE

Amgen’s immuno-oncology drug scores in skin cancer

Firm hoping its novel treatment will be on the market be the end of this year

Sanofi appoints Suresh Kumar as EVP of external affairs

He previously worked for the Clinton Foundation focused on Sub-Saharan Africa

Nabriva Therapeutics names Elyse Seltzer as CMO

She joins from GlaxoSmithKline

EU flag

Three cancer immunotherapies amongst new CHMP approvals

BMS’ Evotaz also amongst eight new medicine recommendations

- PMLiVE

The interactive healthcare environment

It’s no secret that communications in consumer health are changing. Consumers are increasingly keen to interact with brands they know and trust - posing a challenge to traditional ways of...

Webinar: The right e-detailing content for rich data

Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too.

Anthill Agency

- PMLiVE

Clinical research in children lagging, says report

Report found children are missing out on treatment advances that are helping adults

- PMLiVE

Amgen decision on brodalumab unsettles anti-IL-17 class

Move made following data found linking the drug to suicidal thoughts

- PMLiVE

AZ escapes censure over cancer tweet

Firm did not breach UK’s Code of Practice over survival statistics post

- PMLiVE

Disappointment for pharma with new Cancer Drugs Fund list

Bayer the only firm to win a reprieve from the CDF drug cull

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links